Stem cell like memory T cells: A new paradigm in cancer immunotherapy

被引：15

作者：

Wang, Fengdi ^{[1
]}

Cheng, Fanjun ^{[1
]}

Zheng, Fang ^{[2
]}

机构：

[1] Huazhong Univ Sci & Technol, Union Hosp, Inst Hematol, Tongji Med Coll, Wuhan 430022, Hubei, Peoples R China

[2] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Pediat, Wuhan 430022, Hubei, Peoples R China

来源：

CLINICAL IMMUNOLOGY | 2022年 / 241卷

基金：

中国国家自然科学基金;

关键词：

Stem cell like memory T cells; Memory T cells; Cancer immunotherapy; Adoptive cell transfer; Cancer therapeutic vaccines; ADOPTIVE TRANSFER; CD8(+); NAIVE; DIFFERENTIATION; EFFECTOR; PROMOTES; IL-15; LYMPHOCYTES; EXHAUSTION; METABOLISM;

D O I：

10.1016/j.clim.2022.109078

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Stem cell like memory T (T-SCM) cells have emerged as the apex of memory T cell differentiation for their properties of self-renewal and replenishing progenies. With potent long-term persistence, proliferative capacity and antitumor activity, T-SCM cells were thought to be the ideal candidate for cancer immunotherapies. Several strategies have been proposed, such as manipulations of cytokines, metabolic factors, signal pathways, and T cell receptor signal intensity, to induce more T-SCM cells in vitro, in the hope that they could reach a clinical order of magnitude to provide more long-lasting and effective anti-tumor effects in vivo. In this review, we summarized the differentiation characteristics of T-SCM cells and strategies to generate more T-SCM cells. We focused on their roles and application in the cancer immunotherapy especially in adoptive cell transfer therapy and cancer therapeutic vaccines, and hopefully provided clues for future understanding and researches.

引用

页数：11

共 161 条

[1] Enhanced Therapeutic Efficacy and Memory of Tumor-Specific CD8 T Cells by Ex Vivo PI3K-δ Inhibition [J].

Abu Eid, Rasha ;

Ahmad, Shamim ;

Lin, Yuan ;

Webb, Mason ;

Berrong, Zuzana ;

Shrimali, Rajeev ;

Kumai, Takumi ;

Ananth, Sudha ;

Rodriguez, Paulo C. ;

Celis, Esteban ;

Janik, John ;

Mkrtichyan, Mikayel ;

Khleif, Samir N. .

CANCER RESEARCH, 2017, 77 (15) :4135-4145

[2] HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma A Phase 1 Dose-Escalation Trial [J].

Ahmed, Nabil ;

Brawley, Vita ;

Hegde, Meenakshi ;

Bielamowicz, Kevin ;

Kalra, Mamta ;

Landi, Daniel ;

Robertson, Catherine ;

Gray, Tara L. ;

Diouf, Oumar ;

Wakefield, Amanda ;

Ghazi, Alexia ;

Gerken, Claudia ;

Yi, Zhongzhen ;

Ashoori, Aidin ;

Wu, Meng-Fen ;

Liu, Hao ;

Rooney, Cliona ;

Dotti, Gianpietro ;

Gee, Adrian ;

Su, Jack ;

Kew, Yvonne ;

Baskin, David ;

Zhang, Yi Jonathan ;

New, Pamela ;

Grilley, Bambi ;

Stojakovic, Milica ;

Hicks, John ;

Powell, Suzanne Z. ;

Brenner, Malcolm K. ;

Heslop, Helen E. ;

Grossman, Robert ;

Wels, Winfried S. ;

Gottschalk, Stephen .

JAMA ONCOLOGY, 2017, 3 (08) :1094-1101

[3] CD27 Agonism Plus PD-1 Blockade Recapitulates CD4+ T-cell Help in Therapeutic Anticancer Vaccination [J].

Ahrends, Tomasz ;

Babala, Nikolina ;

Xiao, Yanling ;

Yagita, Hideo ;

van Eenennaam, Hans ;

Borst, Jannie .

CANCER RESEARCH, 2016, 76 (10) :2921-2931

[4] CD27, a member of the tumor necrosis factor receptor superfamily, activates NF-KB and stress-activated protein kinase/c-Jun N-terminal kinase via TRAF2, TRAF5, and NF-KB-inducing kinase [J].

Akiba, H ;

Nakano, H ;

Nishinaka, S ;

Shindo, M ;

Kobata, T ;

Atsuta, M ;

Morimoto, C ;

Ware, CF ;

Malinin, NL ;

Wallach, D ;

Yagita, H ;

Okumura, K .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (21) :13353-13358

[5] IL15 Enhances CAR-T Cell Antitumor Activity by Reducing mTORC1 Activity and Preserving Their Stem Cell Memory Phenotype [J].

Alizadeh, Darya ;

Wong, Robyn A. ;

Yang, Xin ;

Wang, Dongrui ;

Pecoraro, Joseph R. ;

Kuo, Cheng-Fu ;

Aguilar, Brenda ;

Qi, Yue ;

Ann, David K. ;

Starr, Renate ;

Urak, Ryan ;

Wang, Xiuli ;

Forman, Stephen J. ;

Brown, Christine E. .

CANCER IMMUNOLOGY RESEARCH, 2019, 7 (05) :759-772

[6] A short CD3/CD28 costimulation combined with IL-21 enhance the generation of human memory stem T cells for adoptive immunotherapy [J].

Alvarez-Fernandez, C. ;

Escriba-Garcia, L. ;

Vidal, S. ;

Sierra, J. ;

Briones, J. .

JOURNAL OF TRANSLATIONAL MEDICINE, 2016, 14

[7] Memory stem T cells modified with a redesigned CD30-chimeric antigen receptor show an enhanced antitumor effect in Hodgkin lymphoma [J].

Alvarez-Fernandez, Carmen ;

Escriba-Garcia, Laura ;

Caballero, A. C. ;

Escudero-Lopez, Eva ;

Ujaldon-Miro, Cristina ;

Montserrat-Torres, Rosanna ;

Pujol-Fernandez, Paula ;

Sierra, Jorge ;

Briones, Javier .

CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2021, 10 (04)

[8] mTOR regulates memory CD8 T-cell differentiation [J].

Araki, Koichi ;

Turner, Alexandra P. ;

Shaffer, Virginia Oliva ;

Gangappa, Shivaprakash ;

Keller, Susanne A. ;

Bachmann, Martin F. ;

Larsen, Christian P. ;

Ahmed, Rafi .

NATURE, 2009, 460 (7251) :108-U124

[9] 4-1BB and Ox40 are members of a tumor necrosis factor (TNF)-nerve growth factor receptor subfamily that bind TNF receptor-associated factors and activate nuclear factor κB [J].

Arch, RH ;

Thompson, CB .

MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (01) :558-565

[10] Notch signaling: Cell fate control and signal integration in development [J].

Artavanis-Tsakonas, S ;

Rand, MD ;

Lake, RJ .

SCIENCE, 1999, 284 (5415) :770-776

← 1 2 3 4 5 6 7 8 9 10 →